Hematopoietic Stem Cell Transplantation for Systemic Sclerosis: Review of Current Status
Crossref DOI link: https://doi.org/10.1007/s40259-019-00364-3
Published Online: 2019-07-13
Published Print: 2019-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Tyndall, Alan
Text and Data Mining valid from 2019-07-13
Version of Record valid from 2019-07-13
Article History
First Online: 13 July 2019
Compliance with Ethical Standards
:
: There was no funding associated with the preparation of this review.
: AT is a co-founder and shareholder of Magenta Therapeutics.